Dutch
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Bladzijde 1 van 43 resultaten
Anti-cancer serine hydrolase inhibitory carbamates
Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
BACKGROUND
A major challenge facing biological researchers in the 21.sup.st century is the functional characterization of the large number of unannotated gene products identified by genome sequencing efforts. Many proteins partly or completely uncharacterized with respect to their biochemical
Modulation of drug resistance via ubiquitin carboxy-terminal hydrolase
Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
BACKGROUND OF THE INVENTION
The field of the invention is modulation of drug resistance.
The concentrations of proteins in biological cells are regulated by elegant biochemical mechanisms. By way of these mechanisms, cells eliminate damaged proteins and can, by altering the concentrations of
Modulation of drug resistance via ubiquitin carboxy-terminal hydrolase
Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
BACKGROUND OF THE INVENTION
The field of the invention is modulation of drug resistance.
The concentrations of proteins in biological cells are regulated by elegant biochemical mechanisms. By way of these mechanisms, cells eliminate damaged proteins and can, by altering the concentrations of
Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
BACKGROUND OF THE INVENTION
SAH hydrolase has been an attractive target for antiviral drug design based on the observation that many viruses require 5'-capped, methylated structures on their mRNA for efficient translation of viral proteins. Yuan et al., Exp. Opin. Ther. Patents, 9: 1197-1206 (1999);
Reversible inhibitors of SAH hydrolase and uses thereof
Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
BACKGROUND OF THE INVENTION
SAH hydrolase has been an attractive target for antiviral drug design based on the observation that many viruses require 5'-capped, methylated structures on their mRNA for efficient translation of viral proteins. Yuan et al., Exp. Opin. Ther. Patents, 9: 1197 1206 (1999);
Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
BACKGROUND OF THE INVENTION
SAH hydrolase has been an attractive target for antiviral drug design based on the observation that many viruses require 5'-capped, methylated structures on their mRNA for efficient translation of viral proteins. Yuan et al., Exp. Opin. Ther. Patents, 9: 1197-1206 (1999);
Acyl-peptide hydrolase and methods of production and use
Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
FIELD OF THE INVENTION
The present invention is directed toward the production of Acyl-Peptide Hydrolase by recombinant DNA technology. It is also directed to the use of the enzyme to catalyze hydrolysis of an acylated peptide or protein, and the reaction between a derivatized N.sup..alpha. -acetyl
Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases
Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
TECHNICAL FIELD
This invention relates generally to certain nucleoside analogues, the use of these compounds as pharmaceuticals, pharmaceutical compositions containing the compounds, processes for preparing the compounds, and methods of treating diseases or conditions in which it is desirable to
Human and rat gamma glutamyl hydrolase genes
Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
FIELD OF THE INVENTION
The present invention relates generally to the peptidase gamma glutamyl hydrolase, and more particularly to nucleic acid molecules encoding gamma glutamyl hydrolase and uses thereof.
BACKGROUND OF THE INVENTION
Throughout this application various publications are referenced,
Human and rat gamma glutamyl hydrolase antibodies
Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
FIELD OF THE INVENTION
The present invention relates generally to the peptidase gamma glutamyl hydrolase, and more particularly to nucleic acid molecules encoding gamma glutamyl hydrolase and uses thereof.
BACKGROUND OF THE INVENTION
Throughout this application various publications are referenced,
Cyanopyrrolidines as dub inhibitors for the treatment of cancer
Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a National Stage Application of PCT/GB2016/052130 filed Jul. 14, 2016, which claims priority from UK Patent Application No. 1512270.8, filed on Jul. 14, 2015 and UK Patent Application No. 1604642.7, filed on Mar. 18, 2016. The priority of
Recombinant bacterial cells for delivery of PNP to tumor cells
Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
SEQUENCE LISTING
This application contains a Sequence Listing that is being submitted herewith as a separate document.
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is in the field of cancer therapy and in particular, relates to compositions and methods to specifically kill
Recombinant bacterial cells for delivery of PNP to tumor cells
Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is in the field of cancer therapy and in particular, relates to compositions and methods to specifically kill tumor cells by the production of toxic compounds in the tumor cells.
2. Description of the Related Art
Inefficiency of
2-cyanoisoindoline derivatives for treating cancer
Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a National Stage Application of PCT/GB2017/050763 filed Mar. 17, 2017, which claims priority from UK Patent Application. No. 1604647.6, filed on Mar. 18, 2016. The priority of said PCT and UK Patent Application are claimed. Each of the
Methods for assessing cancer for increased sensitivity to 10-propargyl-10-deazaaminopterin
Alleen geregistreerde gebruikers kunnen artikelen vertalen
Log in Schrijf in
TECHNICAL FIELD
The present invention relates to methods to treat cancer with 10-propargyl-10-deazaaminopterin and methods for assessing cancers and selecting patients for treatment based for increased sensitivity to 10-propargyl-10-deazaaminopterin.
SEQUENCE INCORPORATED BY REFERENCE
Incorporated
De meest complete database met geneeskrachtige kruiden, ondersteund door de wetenschap
- Werkt in 55 talen
- Kruidengeneesmiddelen gesteund door de wetenschap
- Kruidenherkenning door beeld
- Interactieve GPS-kaart - tag kruiden op locatie (binnenkort beschikbaar)
- Lees wetenschappelijke publicaties met betrekking tot uw zoekopdracht
- Zoek medicinale kruiden op hun effecten
- Organiseer uw interesses en blijf op de hoogte van nieuwsonderzoek, klinische onderzoeken en patenten
Typ een symptoom of een ziekte en lees over kruiden die kunnen helpen, typ een kruid en zie ziekten en symptomen waartegen het wordt gebruikt.
* Alle informatie is gebaseerd op gepubliceerd wetenschappelijk onderzoek
